Certified by Founder
Lodge
SolasCure
start up
United Kingdom
- Cambridge
- 28/03/2023
- Series B
- $13,422,000
SolasCure leverages biomimicry and evidence-based medicine to develop fit for purpose, efficacious wound care products significantly improve the health and wellbeing of patients.
- Industry Biotechnology Research
- Website https://solascure.com/
- LinkedIn https://www.linkedin.com/company/solascure/
Related People
Sam BakriFounder
United Kingdom -
Cambridge, England
Experienced executive and entrepreneur in life sciences, founded and exited life sciences companies in biopharmaceutical and medical devices.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)